These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10225711

  • 1. Predictive factors of response to leukocytapheresis therapy for ulcerative colitis.
    Yajima T, Takaishi H, Kanai T, Iwao Y, Watanabe M, Ishii H, Hibi T.
    Ther Apher; 1998 May; 2(2):115-9. PubMed ID: 10225711
    [Abstract] [Full Text] [Related]

  • 2. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
    Nishioka C, Aoyama N, Maekawa S, Shirasaka D, Nakahara T, Tamura T, Fukagawa M, Umezu M, Abe T, Kasuga M.
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
    [Abstract] [Full Text] [Related]

  • 3. [Mechanism of leukocytapheresis effect in the treatment of ulcerative colitis].
    Sawada K, Ohnishi K, Fukunaga K, Chikano S, Egashira A, Satomi M, Shimoyama T.
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):469-74. PubMed ID: 10726487
    [Abstract] [Full Text] [Related]

  • 4. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis?
    Jo Y, Matsumoto T, Mibu R, Iida M.
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S3-9. PubMed ID: 14530652
    [Abstract] [Full Text] [Related]

  • 5. Leukocytapheresis is effective in inducing but not in maintaining remission in ulcerative colitis.
    Honma T, Sugimura K, Asakura H, Matsuzawa J, Suzuki K, Kobayashi M, Aoyagi Y.
    J Clin Gastroenterol; 2005 Oct; 39(10):886-90. PubMed ID: 16208112
    [Abstract] [Full Text] [Related]

  • 6. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.
    Nagayama K, Takedatsu H, Mitsuyama K, Yamasaki H, Kuwaki K, Yoshioka S, Kobayashi T, Yamauchi R, Kakuma T, Sata M.
    Ther Apher Dial; 2014 Jun; 18(3):244-51. PubMed ID: 24965290
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y, Iwakiri R, Amemori S, Yamaguchi K, Fujise T, Otani H, Shimoda R, Tsunada S, Sakata H, Ikeda Y, Ando T, Nakafusa Y, Fujimoto K.
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [Abstract] [Full Text] [Related]

  • 8. [Leukocytapheresis for ulcerative colitis].
    Fukunaga K, Sawada K, Chikano S, Ohnishi K, Egashira A, Tanaka J, Nagase K, Satomi M, Shimoyama T.
    Nihon Rinsho; 1999 Nov; 57(11):2496-502. PubMed ID: 10572419
    [Abstract] [Full Text] [Related]

  • 9. Extracorporeal leukocyte removal therapy for patients with ulcerative colitis.
    Kumagai M, Yamato Y, Maeda K, Nakashima E, Ushijima K, Kimura A.
    Pediatr Int; 2007 Aug; 49(4):431-6. PubMed ID: 17587263
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
    Nakano R, Iwakiri R, Ikeda Y, Kishi T, Tsuruoka N, Shimoda R, Sakata Y, Yamaguchi K, Fujimoto K.
    J Gastroenterol Hepatol; 2013 Feb; 28(2):303-8. PubMed ID: 23339387
    [Abstract] [Full Text] [Related]

  • 11. A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis.
    Kobayashi T, Matsuoka K, Yokoyama Y, Nakamura T, Ino T, Numata T, Shibata H, Aoki H, Matsuno Y, Hibi T.
    J Gastroenterol; 2018 Mar; 53(3):387-396. PubMed ID: 28597225
    [Abstract] [Full Text] [Related]

  • 12. [Remission by leukocytapheresis for a patient with ulcerative colitis found refractory by conventional drug therapies].
    Sawada K, Ohnishi K, Kosaka T, Egashira A, Kinoshita T, Amano K, Yamamura M, Satomi M, Shimoyama T.
    Nihon Rinsho Meneki Gakkai Kaishi; 1997 Apr; 20(2):126-33. PubMed ID: 9178970
    [Abstract] [Full Text] [Related]

  • 13. [Leukocytapheresis for ulcerative colitis].
    Sawada K, Ohnishi K, Kosaka T, Egashira A, Yamamura M, Satomi M, Shimoyama T.
    Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):438-42. PubMed ID: 9168498
    [Abstract] [Full Text] [Related]

  • 14. Relationship between ulcerative colitis patients treated with leukocytapheresis and ulcerative colitis-associated colorectal cancer.
    Kinugasa T, Akagi Y, Murotani K, Romeo K, Yoshida T, Ryu Y, Shiratuchi I, Shirouzu K.
    Anticancer Res; 2011 Jul; 31(7):2547-52. PubMed ID: 21873173
    [Abstract] [Full Text] [Related]

  • 15. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column.
    Sawada K, Muto T, Shimoyama T, Satomi M, Sawada T, Nagawa H, Hiwatashi N, Asakura H, Hibi T.
    Curr Pharm Des; 2003 Jul; 9(4):307-21. PubMed ID: 12570823
    [Abstract] [Full Text] [Related]

  • 16. Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis.
    Umehara Y, Kudo M, Kawasaki M.
    World J Gastroenterol; 2008 Sep 14; 14(34):5316-21. PubMed ID: 18785285
    [Abstract] [Full Text] [Related]

  • 17. Poorly controlled ulcerative colitis treated by colectomy during remission induced by extracorporeal leukocyte removal therapy.
    Fukunaga K, Fukuda Y, Sawada K, Hori K, Matoba Y, Sagayama K, Ohnishi K, Fukui S, Shimoyama T.
    J Gastroenterol; 2003 Sep 14; 38(7):684-9. PubMed ID: 12898362
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic efficacy of leukocytapheresis in a pregnant woman with severe active ulcerative colitis.
    Okada H, Makidono C, Takenaka R, Hiraoka S, Fujiwara A, Kato J, Kawahara Y, Kawamoto H, Mizuno M, Shiratori Y.
    Digestion; 2006 Sep 14; 74(1):15-8. PubMed ID: 16940730
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of leukocytapheresis in elderly patients with ulcerative colitis: The impact in steroid-free elderly patients.
    Komoto S, Matsuoka K, Kobayashi T, Yokoyama Y, Suzuki Y, Hibi T, Miura S, Hokari R.
    J Gastroenterol Hepatol; 2018 Aug 14; 33(8):1485-1491. PubMed ID: 29406567
    [Abstract] [Full Text] [Related]

  • 20. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.
    Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kikuyama M, Tanaka T, Kondo K, Tanaka K, Takai K.
    World J Gastroenterol; 2005 May 28; 11(20):3085-90. PubMed ID: 15918195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.